Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
NCT: NCT06467695 · RECRUITING
Brief Summary
The goal of this clinical trial is to determine the relative efficacy of fMRI model guided Transcranial Direct Current Stimulation (mgTDCS) in improving the depressive symptoms of patients with Parkinson's Disease (PD). The main questions it aims to answer are: 1) Can the use of mgTDCS significantly improve the self-reported level of depression and apathy in patients with PD from pre-intervention to post-intervention compared to a sham control? 2) Can the use of mgTDCS significantly normalize the cortical eeg alpha asymmetry so commonly seen in depressed patients compared to sham mgTDCS? 3) Can the use of mgTDCS significantly improve scores on neuropsychological tests of working memory?
Frequently Asked Questions
What is Low Voltage Electrical Stimulation for Depression in Parkinson's Patients?
Low Voltage Electrical Stimulation for Depression in Parkinson's Patients is a clinical trial registered under NCT06467695. Current status: RECRUITING.
What is the status of NCT06467695?
The current status of NCT06467695 (Low Voltage Electrical Stimulation for Depression in Parkinson's Patients) is: RECRUITING.
When did Low Voltage Electrical Stimulation for Depression in Parkinson's Patients start?
Low Voltage Electrical Stimulation for Depression in Parkinson's Patients started on 2024-08-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.